b. Emergent In-Office Use.
It was pointed out that the ability to obtain non-patient specific
sterile compounds for emergent in-office use is critical for the
immediate treatment of urgent conditions that require timely
administration of medications to prevent negative health care
outcomes. It was recommended that the definition of “emergent”
include any diagnosis where treatment with a sterile compounded
medication within 72 business hours is clinically necessary to
prevent adverse health outcomes.
The Board notes that within a 72 hour window a patient specific
prescription could be made available to obtain the medications
needed and would not be an emergent reason for a waiver. In
addition, compounding under urgent conditions becomes a patient